January 23rd, 2026 — Golden Stapler Surgical Co., Ltd (Golden Stapler), announced that its new generation Powered Endoscopic Cutter has officially obtained the NMPA Class III medical device registration certificate.

This milestone marks Golden Stapler’s important breakthrough in the field of minimally invasive surgical instruments and signifies that its independently developed electric endoscopic cutting technology has met China’s highest-level medical device safety and efficacy standards.

As a high-tech enterprise dedicated to the innovative R&D, high-quality production, and professional promotion of minimally invasive anastomosis technologies, Golden Stapler was founded in 2008. Its core products, manual and powered Endo cutting staplers, are widely used in various high-difficulty surgical procedures, including thoracic and general surgery, effectively simplifying surgical workflows and enhancing operational convenience and safety.

The Class III medical device registration certificate represents a stringent access approval issued by the National Medical Products Administration (NMPA) for high-risk medical devices. The approval process is complex, requires significant R&D investment, and imposes extremely high standards on product safety, efficacy, and quality control. The value of this certificate directly reflects a company’s core competitiveness. The recent approval of the Class III powered endoscopic linear cutting stapler registration certificate not only strongly affirms Golden Stapler’s R&D innovation capabilities and product quality, but also broadens the Golden Stapler’s market presence and strengthens its core competitiveness in the field of minimally invasive surgical instruments.

Looking ahead, Golden Stapler will continue to increase R&D investment, deepen its focus on the minimally invasive medical device field, achieve new generation product design, contribute further to clinical medical advancement.